Clinical Trial Update: Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium. [Phase 3]

View source ↗

Summary

Phase 3 trial in non-cystic fibrosis bronchiectasis evaluating colistimethate sodium was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• Colistimethate Sodium (Colistimethate Sodium)

Snippet

Sponsor: Zambon SpA | Conditions: Non Cystic Fibrosis Bronchiectasis | Phase 3 | Status: TERMINATED | Results posted: 2023-12-29